Clinical Trials in Surrey Quays

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Download CSV

Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 2852 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 17 Sep 2026, 08:23 UTC

2852

Studies in scope

industry-sponsored, all four open statuses

1378

Recruiting now

open to new participants

540

Lead sponsors

across recruiting studies

Top sites

London 12 Manchester 5 Sutton 4 Bristol 3 Cambridge 3

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site city

All 24 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

NCT04446117Metastatic Prostate Cancer, Prostate Adenocarcinoma

Exelixis

Phase 3

575

London, Surrey Quays, Taunton, Blackburn, Northwood, Swansea

2020-10-19

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-uk/city/surrey-quays

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the UK Pharma Salary Guide, or see the Ireland, EU and USA registers.